
Jean F. Voltaire
Examiner (ID: 18083, Phone: (571)272-3953 , Office: P/2466 )
| Most Active Art Unit | 2466 |
| Art Unit(s) | 2466, 2417 |
| Total Applications | 487 |
| Issued Applications | 381 |
| Pending Applications | 55 |
| Abandoned Applications | 68 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5379354
[patent_doc_number] => 20090191193
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-30
[patent_title] => 'Aryl Vinyl Sulfides, Sulfones, Sulfoxides and Sulfonamides, Derivatives Thereof and Therapeutic Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/309620
[patent_app_country] => US
[patent_app_date] => 2007-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41972
[patent_no_of_claims] => 131
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20090191193.pdf
[firstpage_image] =>[orig_patent_app_number] => 12309620
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/309620 | Aryl Vinyl Sulfides, Sulfones, Sulfoxides and Sulfonamides, Derivatives Thereof and Therapeutic Uses Thereof | Jul 31, 2007 | Abandoned |
Array
(
[id] => 5199820
[patent_doc_number] => 20070299138
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-27
[patent_title] => 'ST104P, An Anti-Angiogenic Agent'
[patent_app_type] => utility
[patent_app_number] => 11/830334
[patent_app_country] => US
[patent_app_date] => 2007-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 5849
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0299/20070299138.pdf
[firstpage_image] =>[orig_patent_app_number] => 11830334
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/830334 | ST104P, An Anti-Angiogenic Agent | Jul 29, 2007 | Abandoned |
Array
(
[id] => 10147853
[patent_doc_number] => 09180118
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-11-10
[patent_title] => 'Thiadiazolidinone derivatives'
[patent_app_type] => utility
[patent_app_number] => 12/374002
[patent_app_country] => US
[patent_app_date] => 2007-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 17641
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12374002
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/374002 | Thiadiazolidinone derivatives | Jul 17, 2007 | Issued |
Array
(
[id] => 5429168
[patent_doc_number] => 20090088478
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-02
[patent_title] => 'NOVEL COMPOUNDS AS HISTONE DEACETYLASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 11/778297
[patent_app_country] => US
[patent_app_date] => 2007-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7919
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0088/20090088478.pdf
[firstpage_image] =>[orig_patent_app_number] => 11778297
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/778297 | Compounds as histone deacetylase inhibitors | Jul 15, 2007 | Issued |
Array
(
[id] => 7774351
[patent_doc_number] => 08119638
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-02-21
[patent_title] => 'Compositions and uses of ET743 for treating cancer'
[patent_app_type] => utility
[patent_app_number] => 11/769873
[patent_app_country] => US
[patent_app_date] => 2007-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3833
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/119/08119638.pdf
[firstpage_image] =>[orig_patent_app_number] => 11769873
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/769873 | Compositions and uses of ET743 for treating cancer | Jun 27, 2007 | Issued |
Array
(
[id] => 4670535
[patent_doc_number] => 20080045595
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-21
[patent_title] => 'METHOD OF TREATING CANCER'
[patent_app_type] => utility
[patent_app_number] => 11/769322
[patent_app_country] => US
[patent_app_date] => 2007-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11800
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20080045595.pdf
[firstpage_image] =>[orig_patent_app_number] => 11769322
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/769322 | METHOD OF TREATING CANCER | Jun 26, 2007 | Abandoned |
Array
(
[id] => 5480813
[patent_doc_number] => 20090203770
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-13
[patent_title] => 'COMPOSITIONS AND METHODS FOR MODULATING APOPTOSIS IN CELLS OVER-EXPRESSING Bcl-2 FAMILY MEMBER PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 11/768111
[patent_app_country] => US
[patent_app_date] => 2007-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 20215
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20090203770.pdf
[firstpage_image] =>[orig_patent_app_number] => 11768111
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/768111 | COMPOSITIONS AND METHODS FOR MODULATING APOPTOSIS IN CELLS OVER-EXPRESSING Bcl-2 FAMILY MEMBER PROTEINS | Jun 24, 2007 | Abandoned |
Array
(
[id] => 5211067
[patent_doc_number] => 20070249651
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-25
[patent_title] => 'Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and topoisomerase I and II inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/821333
[patent_app_country] => US
[patent_app_date] => 2007-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2550
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0249/20070249651.pdf
[firstpage_image] =>[orig_patent_app_number] => 11821333
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/821333 | Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and topoisomerase I and II inhibitors | Jun 21, 2007 | Abandoned |
Array
(
[id] => 4892935
[patent_doc_number] => 20080102033
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-01
[patent_title] => 'PREPARATION FOR THE PROPHYLAXIS OF RESTENOSIS'
[patent_app_type] => utility
[patent_app_number] => 11/763116
[patent_app_country] => US
[patent_app_date] => 2007-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4076
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0102/20080102033.pdf
[firstpage_image] =>[orig_patent_app_number] => 11763116
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/763116 | PREPARATION FOR THE PROPHYLAXIS OF RESTENOSIS | Jun 13, 2007 | Abandoned |
Array
(
[id] => 4892936
[patent_doc_number] => 20080102034
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-01
[patent_title] => 'PREPARATION FOR THE PROPHYLAXIS OF RESTENOSIS'
[patent_app_type] => utility
[patent_app_number] => 11/763125
[patent_app_country] => US
[patent_app_date] => 2007-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4074
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0102/20080102034.pdf
[firstpage_image] =>[orig_patent_app_number] => 11763125
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/763125 | PREPARATION FOR THE PROPHYLAXIS OF RESTENOSIS | Jun 13, 2007 | Abandoned |
Array
(
[id] => 7503794
[patent_doc_number] => 08034834
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-10-11
[patent_title] => 'Method for treating proliferative disorders with HSP90 inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/807354
[patent_app_country] => US
[patent_app_date] => 2007-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 22
[patent_no_of_words] => 114143
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/034/08034834.pdf
[firstpage_image] =>[orig_patent_app_number] => 11807354
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/807354 | Method for treating proliferative disorders with HSP90 inhibitors | May 24, 2007 | Issued |
Array
(
[id] => 5465856
[patent_doc_number] => 20090326056
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-31
[patent_title] => 'NOVEL ACTIVES AGAINST PROSTATE CARCINOMA'
[patent_app_type] => utility
[patent_app_number] => 12/299825
[patent_app_country] => US
[patent_app_date] => 2007-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3451
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0326/20090326056.pdf
[firstpage_image] =>[orig_patent_app_number] => 12299825
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/299825 | NOVEL ACTIVES AGAINST PROSTATE CARCINOMA | May 14, 2007 | Abandoned |
Array
(
[id] => 5380319
[patent_doc_number] => 20090192158
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-30
[patent_title] => 'Methods for Treating or Preventing Neoplasias'
[patent_app_type] => utility
[patent_app_number] => 12/226169
[patent_app_country] => US
[patent_app_date] => 2007-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 22478
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20090192158.pdf
[firstpage_image] =>[orig_patent_app_number] => 12226169
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/226169 | Methods for Treating or Preventing Neoplasias | Apr 29, 2007 | Abandoned |
Array
(
[id] => 5070365
[patent_doc_number] => 20070191467
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-16
[patent_title] => 'STATIN AND OMEGA-3 FATTY ACIDS FOR LIPID THERAPY'
[patent_app_type] => utility
[patent_app_number] => 11/742292
[patent_app_country] => US
[patent_app_date] => 2007-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8032
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20070191467.pdf
[firstpage_image] =>[orig_patent_app_number] => 11742292
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/742292 | STATIN AND OMEGA-3 FATTY ACIDS FOR LIPID THERAPY | Apr 29, 2007 | Abandoned |
Array
(
[id] => 5465857
[patent_doc_number] => 20090326057
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-31
[patent_title] => 'THERAPEUTIC USES OF UROLITHINS'
[patent_app_type] => utility
[patent_app_number] => 12/298122
[patent_app_country] => US
[patent_app_date] => 2007-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 12019
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0326/20090326057.pdf
[firstpage_image] =>[orig_patent_app_number] => 12298122
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/298122 | Therapeutic uses of urolithins | Apr 25, 2007 | Issued |
Array
(
[id] => 7966565
[patent_doc_number] => 07939557
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-05-10
[patent_title] => 'Vascular endothelial receptor specific inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/737375
[patent_app_country] => US
[patent_app_date] => 2007-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18656
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/939/07939557.pdf
[firstpage_image] =>[orig_patent_app_number] => 11737375
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/737375 | Vascular endothelial receptor specific inhibitors | Apr 18, 2007 | Issued |
Array
(
[id] => 5231440
[patent_doc_number] => 20070293548
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-20
[patent_title] => 'Inhibitors of semicarbazide-sensitive amine oxidase (SSAO) and VAP-1 mediated adhesion useful for treatment and prevention of diseases'
[patent_app_type] => utility
[patent_app_number] => 11/731819
[patent_app_country] => US
[patent_app_date] => 2007-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 81419
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0293/20070293548.pdf
[firstpage_image] =>[orig_patent_app_number] => 11731819
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/731819 | Inhibitors of semicarbazide-sensitive amine oxidase (SSAO) and VAP-1 mediated adhesion useful for treatment and prevention of diseases | Mar 29, 2007 | Abandoned |
Array
(
[id] => 6637051
[patent_doc_number] => 20100035876
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-11
[patent_title] => 'Use of a Kinase Inhibitor for the Treatment of Particular Resistant Tumors'
[patent_app_type] => utility
[patent_app_number] => 12/293985
[patent_app_country] => US
[patent_app_date] => 2007-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7858
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20100035876.pdf
[firstpage_image] =>[orig_patent_app_number] => 12293985
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/293985 | Use of a kinase inhibitor for the treatment of particular resistant tumors | Mar 28, 2007 | Issued |
Array
(
[id] => 5029043
[patent_doc_number] => 20070270490
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-22
[patent_title] => 'USE OF (-)(3-TRIHALOMETHYLPHENOXY)(4-HALOPHENYL) ACETIC ACID DERIVATIVES FOR TREATMENT OF INSULIN RESISTANCE, TYPE 2 DIABETES AND HYPERLIPIDEMIA'
[patent_app_type] => utility
[patent_app_number] => 11/690026
[patent_app_country] => US
[patent_app_date] => 2007-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 16548
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0270/20070270490.pdf
[firstpage_image] =>[orig_patent_app_number] => 11690026
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/690026 | USE OF (-)(3-TRIHALOMETHYLPHENOXY)(4-HALOPHENYL) ACETIC ACID DERIVATIVES FOR TREATMENT OF INSULIN RESISTANCE, TYPE 2 DIABETES AND HYPERLIPIDEMIA | Mar 21, 2007 | Abandoned |
Array
(
[id] => 4932502
[patent_doc_number] => 20080003277
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-03
[patent_title] => 'Agent for improving tissue penetration'
[patent_app_type] => utility
[patent_app_number] => 11/716669
[patent_app_country] => US
[patent_app_date] => 2007-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11798
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20080003277.pdf
[firstpage_image] =>[orig_patent_app_number] => 11716669
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/716669 | Agent for improving tissue penetration | Mar 11, 2007 | Abandoned |